There are many kinds of muscular dystrophies, which are caused by genetic mutations. These diseases reduce mobility, and complicate everyday tasks. Various types of muscular dystrophies can affect ...

Capricor Therapeutics has presented positive long-term data from its HOPE-2 clinical trial at the 2025 Muscular Dystrophy Association Conference, indicating that its leading treatment, deramiocel, can ...

Investigators at University of British Columbia have reported the precise cellular populations responsible for the inability to regenerate muscle tissues in muscular dystrophy. The team also showed ...

Economic Impact of Disease Progression Disease progression stages and burden in patients with Duchenne muscular dystrophy using administrative claims supplemented by electronic medical records ...

A new surprise discovery could hold big implications for muscular dystrophy patients, with researchers finding that an existing cancer drug may delay progression of the hard-to-treat disease.

It wasn’t the best of news for sufferers of Duchenne muscular dystrophy (DMD). But neither was it dismal. It does appear that the first FDA-approved gene therapy, called Elevidys, can, with a one-time ...

Please provide your email address to receive an email when new articles are posted on . Emflaza, a corticosteroid, improved or stabilized disease progression in most patients with Duchenne muscular ...

Please provide your email address to receive an email when new articles are posted on . Researchers determined deltoid muscle strength to be the top clinical outcome measure when it comes to capturing ...

Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy. Duchenne muscular dystrophy (DMD) is a ...

Sarepta’s trial supports its drug’s ‘potentially differentiated profile’ to treat Duchenne muscular dystrophy, the company said. The stock is higher. Sarepta Therapeutics (SRPT) shares jumped Tuesday ...

WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is pleased to announce the ...